Hironori Yamamoto Selected Research

1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamine

12/2022	Long-term changes in serum gastrin levels during standard dose vonoprazan therapy.
1/2022	Predictors and timing for the development of symptomatic gastroesophageal reflux disease after successful Helicobactor pylori eradication therapy.
3/2021	Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.
8/2018	Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
12/2017	Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease.
9/2017	Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hironori Yamamoto Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 10/2004
19	Hemorrhage 07/2022 - 06/2004
13	Pathologic Constriction (Stenosis) 01/2011 - 02/2005
11	Chronic Renal Insufficiency 01/2022 - 08/2007
10	Stomach Neoplasms (Stomach Cancer) 05/2022 - 12/2005
10	Hyperphosphatemia 11/2020 - 04/2002
9	Infections 01/2022 - 09/2006
8	Inflammation (Inflammations) 02/2019 - 02/2005
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2014
6	Polyps 12/2022 - 04/2005
6	Liver Cirrhosis (Hepatic Cirrhosis) 08/2021 - 02/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 11/2005
6	Fatty Liver 06/2019 - 07/2009
5	Gastroesophageal Reflux (GERD) 01/2022 - 09/2017
4	Pain (Aches) 10/2022 - 01/2016
4	Fibrosis (Cirrhosis) 01/2022 - 04/2006
4	Ulcer 01/2022 - 10/2007
4	Obesity 11/2017 - 05/2007
4	Body Weight (Weight, Body) 11/2017 - 01/2007
4	Weight Loss (Weight Reduction) 11/2017 - 01/2009
4	Insulin Resistance 04/2012 - 11/2005
4	Hyperglycemia 12/2007 - 11/2005
3	Intussusception 01/2021 - 07/2008
3	Heart Failure 11/2020 - 06/2013
3	Dyspepsia (Indigestion) 01/2020 - 01/2016
3	Ulcerative Colitis 01/2020 - 06/2002
3	Hypercholesterolemia 02/2019 - 01/2013
3	Hyperlipidemias (Hyperlipidemia) 01/2015 - 08/2007
3	Hypophosphatemia 01/2013 - 04/2002
3	Gastritis 02/2011 - 10/2003
3	Wounds and Injuries (Trauma) 01/2009 - 10/2004
2	Atrophy 12/2022 - 08/2010
2	Esophageal Achalasia (Megaesophagus) 10/2022 - 09/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2004
2	Necrosis 06/2021 - 06/2002
2	Diarrhea 03/2021 - 12/2017
2	Constipation 03/2021 - 12/2017
2	Pancreatitis 01/2021 - 04/2006
2	COVID-19 10/2020 - 07/2020
2	Chronic Hepatitis C 10/2020 - 02/2019
2	Muscular Atrophy (Muscle Atrophy) 09/2020 - 10/2010
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2019 - 06/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2019 - 11/2005
2	Adenoma (Adenomas) 01/2019 - 11/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2017 - 01/2009
2	Anemia 11/2015 - 08/2005
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 11/2015 - 02/2011
2	Hypertriglyceridemia 01/2015 - 07/2009
2	Communicable Diseases (Infectious Diseases) 12/2014 - 01/2009
2	Hyperthyroidism 01/2014 - 02/2013
2	Atherosclerosis 07/2013 - 09/2011

Drug/Important Bio-Agent (IBA)

13	Phosphates (Orthophosphate)IBA 09/2017 - 01/2004
9	Capsules (Microcapsules)IBA 07/2020 - 04/2005
7	Glucose (Dextrose)FDA LinkGeneric 04/2012 - 01/2005
6	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 12/2022 - 09/2017
6	Vitamin D FDA LinkGeneric 01/2020 - 07/2002
6	Phosphorus (Red Phosphorus)IBA 01/2014 - 04/2002
5	LipidsIBA 02/2021 - 08/2008
5	CholesterolIBA 02/2021 - 07/2012
5	Messenger RNA (mRNA)IBA 11/2017 - 12/2005
4	AnticoagulantsIBA 01/2022 - 06/2004
4	SolutionsIBA 05/2021 - 05/2008
4	Dietary PhosphorusIBA 11/2020 - 01/2007
4	Hyaluronic Acid (Hyaluronan)IBA 06/2018 - 07/2005
4	isomaltulose (palatinose)IBA 09/2009 - 11/2005
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2009 - 08/2005
3	AcidsIBA 12/2022 - 09/2017
3	Proton Pump InhibitorsIBA 01/2022 - 09/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 08/2005
3	Z 338IBA 01/2020 - 01/2016
3	SodiumIBA 04/2014 - 08/2007
3	CalciumIBA 02/2013 - 01/2004
3	Fibroblast Growth Factor-23IBA 02/2013 - 01/2004
3	CytokinesIBA 08/2010 - 06/2002
3	Hemostatics (Antihemorrhagics)IBA 01/2009 - 07/2005
2	HDL LipoproteinsIBA 02/2021 - 01/2015
2	SofosbuvirIBA 01/2021 - 02/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2008
2	IronIBA 11/2015 - 02/2011
2	MineralsIBA 01/2015 - 01/2014
2	SteroidsIBA 12/2014 - 06/2009
2	1,25-dihydroxyvitamin DIBA 02/2013 - 07/2002

Therapy/Procedure

17	Therapeutics 12/2022 - 12/2005
8	Lasers (Laser) 11/2022 - 01/2014
8	Endoscopes 07/2022 - 08/2005
5	Surgical Instruments (Clip) 05/2021 - 07/2005
5	Laparotomy 01/2021 - 01/2008
5	Radiofrequency Ablation 10/2020 - 12/2014
4	Endoscopic Hemostasis 07/2022 - 10/2003
4	Electrocoagulation (Electrocautery) 06/2021 - 10/2004
4	Liver Transplantation 01/2011 - 12/2005
4	Operative Surgical Procedures 06/2009 - 02/2005
3	Traction 05/2021 - 09/2020
3	Argon Plasma Coagulation 07/2020 - 10/2003
2	Myotomy 10/2022 - 09/2020
2	Ligation 01/2022 - 08/2019
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2021 - 01/2021
2	Colonoscopes 08/2019 - 01/2018
2	Ovariectomy (Oophorectomy) 08/2016 - 01/2009
2	Blood Component Removal (Apheresis) 12/2014 - 06/2002